ViroCyt Launches Improved Virus Counter Reagent System
DENVER, CO–(Marketwired – Jun 4, 2013) – ViroCyt, LLC, the leader in the field of rapid virus quantification, today announced the availability of the Virus Counter Reagent Kit 200 for use with the Virus Counter 2100. The new system allows up to 200 samples to be run, instead of the previous amount of 50. This results in a significant decrease in per sample cost for the end user as well as the added financial and environmental benefits resulting from reduced packaging and shipping.
According to Robert Kline, President and CEO of ViroCyt, “The Virus Counter® 2100 permits quantification of intact viral particles in minutes, instead of the days or weeks and hundreds or even thousands of dollars per sample for outdated methods such as electron microscopy or plaque titer. This new reagent system is consistent with our ongoing efforts to provide innovative and cost-effective solutions for the life science industry.”
Added Alex Beljaars, President of IUL Instruments, “As the distributor of the Virus Counter in Western Europe we have been delighted by the increasing demand for the instrument in the region. This technology is truly a game-changer for companies and universities working with viruses. By lowering the per sample cost of the reagents, the value proposition is even more compelling.”
The primary application of the Virus Counter is in settings in which viruses are utilized directly as vaccines or to express proteins, which are subsequently used as therapies or vaccines. Virus Counter eliminates bottlenecks in critical development and manufacturing processes, replacing outdated viral quantification methods while delivering improved accuracy and significant cost savings.
About ViroCyt, LLC
ViroCyt was created with the goal of bringing game-changing solutions to the Life Science industry. Our primary focus is replacing outdated technologies that slow down the pace of virus-related research and product development. To learn more about ViroCyt, go to http://www.virocyt.com.
VP Marketing & Strategic Partnering
Source: ViroCyt, LLC